| Literature DB >> 26316966 |
Velia Ramírez-Amador1, Gabriela Anaya-Saavedra1, Brenda Crabtree-Ramírez2, Lilly Esquivel-Pedraza3, Marcela Saeb-Lima4, Juan Sierra-Madero2.
Abstract
Background. Oral lesions may constitute the first clinical manifestation in secondary syphilis, but detailed descriptions in HIV-infected individuals are scarce. Objective. To describe the clinical characteristics of oral secondary syphilis in HIV-infected patients and its relevance in the early diagnosis of syphilis. Methods. Twenty HIV/AIDS adult subjects with oral secondary syphilis lesions presenting at two HIV/AIDS referral centers in Mexico City (2003-2011) are described. An oral examination was performed by specialists in oral pathology and medicine; when possible, a punch biopsy was done, and Warthin-Starry stain and immunohistochemistry were completed. Intraoral herpes virus infection and erythematous candidosis were ruled out by cytological analysis. Diagnosis of oral syphilis was confirmed with positive nontreponemal test (VDRL), and, if possible, fluorescent treponemal antibody test. Results. Twenty male patients (median age 31.5, 21-59 years) with oral secondary syphilis lesions were included. Oral lesions were the first clinical sign of syphilis in 16 (80%) cases. Mucous patch was the most common oral manifestation (17, 85.5%), followed by shallow ulcers (2, 10%) and macular lesions (1, 5%). Conclusions. Due to the recent rise in HIV-syphilis coinfection, dental and medical practitioners should consider secondary syphilis in the differential diagnosis of oral lesions, particularly in HIV-infected patients.Entities:
Year: 2012 PMID: 26316966 PMCID: PMC4437426 DOI: 10.1155/2013/892427
Source DB: PubMed Journal: J Sex Transm Dis ISSN: 2090-7958
Clinical characteristics in 20 patients with oral syphilis.
| Characteristics |
|
|---|---|
| AIDSa | 10 (50.0) |
| On HAART | 14 (70.0) |
| Tobacco consumption ( | 6 (31.6) |
| Alcohol consumption ( | 4 (21.1) |
| Main type of lesion | |
| Mucous patches | 17 (85.5) |
| Shallow ulcers | 2 (10.0) |
| Macular lesions | 1 (5.0) |
| Oral site of main lesionb | |
| Soft palate-pillars | 8 (40.0) |
| Hard palate | 3 (15.0) |
| Tongue | 3 (15.0) |
| Hard-soft palate-pillars | 2 (10.0) |
| Hard-soft palate-tongue | 1 (5.0) |
| Hard-soft palate-tongue-buccal mucosa | 1 (5.0) |
| Upper labial mucosa | 1 (5.0) |
| Gingiva | 1 (5.0) |
| Minor type of lesion ( | |
| Papular lesions | 4 (40.0) |
| Macular lesions | 4 (40.0) |
| Shallow ulcers | 2 (20.0) |
| Oral site of minor lesion ( | |
| Tongue | 5 (50.0) |
| Hard palate | 3 (30.0) |
| Gingiva/labial mucosa | 1 (10.0) |
| Soft palate | 1 (10.0) |
| Median antiretroviral use (range) months | 32.5 (1–134) |
| With undetectable viral load (<399 copies/mL) ( | 10 (52.6) |
| Current median CD4+ count (range) cells/ | 372 (44–734) |
a CD4+ T-lymphocyte count of <200 cells/μL (or <14 percentage) and/or documentation of an AIDS-defining condition (A3, B3, C1–3) [37]. bMain oral lesion was the most evident and florid oral manifestation.
Figure 1Oral secondary syphilis. White slightly raised plaques with a serpentine and white/reddish well-defined outline, located on hard, soft palate, pillars (a–c), and gingiva (d).
Clinical characteristics of 20 patients with oral secondary syphilis.
| ID | Clinical stagea | Current VL | Current CD4+
| Oral lesion | Site | VDRL dilution | FTA-ABS |
|---|---|---|---|---|---|---|---|
| 1 | B2 | 6,310 | 378 | Shallow ulcer | Hard palate | 1 : 16 | ++++ |
| 2 | C3 | UND | 202 | Mucous patches | Hard palate | 1 : 8 | ++ |
| 3 | C1 | NA | NA | Mucous patches | Soft palate-pillars | 1 : 32 | ++++ |
| 4 | C3 | 5,470 | 217 | Mucous patches | Soft palate-pillars | 1 : 256 | +++ |
| 5 | A3 | 56,500 | 168 | Mucous patches | Soft palate-pillars | 1 : 128 | +++ |
| 6 | A2 | 100,000 | 239 | Mucous patches | Soft palate-pillars | 1 : 128 | +++ |
| 7 | A1 | 9,656 | 681 | Shallow ulcers | Upper labial mucosa | 1 : 32 | NA |
| 8 | B3 | UND | 458 | Mucous patches | Soft palate-pillars | 1 : 512 | +++ |
| 9 | C3 | 239,146 | 44 | Macular lesion | Dorsal lingual | 1 : 2 | +++ |
| 10 | C3 | UND | 372 | Mucous patches | Soft palate-pillars | 1 : 128 | +++ |
| 11 | A1 | 47,011 | 603 | Mucous patches | Hard palate | 1 : 2 | + |
| 12 | A1 | 13,259 | 648 | Mucous patches | Hard-soft palate-pillars | 1 : 4 | + |
| 13 | C2 | UND | 715 | Mucous patches | Gingiva | 1 : 64 | +++ |
| 14 | C2 | UND | 360 | Mucous patches | Hard-soft palate-tongue | 1 : 32 | NA |
| 15 | C3 | UND | 187 | Mucous patches | Soft palate-pillars | 1 : 128 | +++ |
| 16 | C3 | UND | 348 | Mucous patches | Soft palate-pillars, tongue | 1 : 32 | NA |
| 17 | B3 | UND | 370 | Mucous patches | Lateral sides of tongue | 1 : 32 | NA |
| 18 | C3 | UND | 392 | Mucous patches | Soft palate-pillars | 1 : 32 | NA |
| 19 | A1 | UND | 734 | Mucous patches | Hard-soft palate-pillars | 1 : 64 | +++ |
| 20 | A1 | 205,000 | 532 | Mucous patches | Lateral tongue | 1 : 64 | ++ |
ID: identification, aaccording to the CDC revised surveillance case definitions [37], VL: viral load, VDRL: venereal disease research laboratory, FTA-ABS: fluorescent treponemal antibody absorbed, UND: undetectable, NA: not available.
Figure 2Oral secondary syphilis. Papular lesions on the dorsum of the tongue mimicking erythematous candidosis (a), mucous patches, hairy leukoplakia-like, on the lateral side of the tongue (b).
Figure 3Oral secondary syphilis. Shallow ulcers on the hard palate mimicking intraoral herpes virus infection.
Figure 4Secondary syphilis. H&E stain (4x) shows a psoriasiform and lichenoid lymphoplasmacytic estomatitis with neutrophilic microabscesses in the stratum corneum (a), Warthin Starry stain (10x) shows a spirochete within the epithelium (dark small arrow) (b), and Treponema pallidum antibody (20x) shows multiple spirochetes within the epithelium (c).